Strong Revenue Growth
Reported 17% revenue growth in Q3 2024 compared to the same period last year, with total revenue reaching $9.6 million, up from $8.2 million in Q3 2023.
Increase in Clinical Solutions Revenue
Clinical Solutions revenue was $2.0 million in Q3 2024, a 229% increase from $0.6 million in Q3 2023, driven by an increased number of customers and higher average revenue per customer.
Reduction in Operating Expenses
Operating expenses for Q3 2024 were $7.5 million, down from $10.2 million in Q3 2023, owing to reduced headcount and spending, especially on professional fees.
Improved Free Cash Outflow
Free cash outflow decreased to $2.4 million in Q3 2024, the lowest level since the IPO in the second quarter of 2021, compared to $5.4 million in Q3 2023.